article thumbnail

Treating COVID-19: A pharmaceutical executive’s view

McKinsey

Cedric Francois, the CEO of pharmaceutical company Apellis, discusses possible approaches to treating COVID-19 patients.

article thumbnail

HR Challenges in the Pharmaceutical Industries

Vantage Circle

All of which will imply how the pharmaceutical industry is likely to conduct its business in the near future. With the constant layoffs, corporate mergers and acquisitions in the pharmaceutical market, and rise in the compensation standards, many businesses have also adopted an outsourcing business model. Development in Technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A ‘GOLD standard’ in brand growth for Japan’s pharmaceutical market

McKinsey

Our GOLD standard will help transform your pharmaceutical brand and achieve accelerated growth.

article thumbnail

First-time launchers in the pharmaceutical industry

McKinsey

Increasingly, small biopharmaceutical companies are launching their new drugs themselves rather than relying on large pharma companies to do it for them. How can they get it right the first time?

article thumbnail

Can a Japanese pharmaceutical become a social innovator?

McKinsey

Santen CIO Minori Hara explains how IT is enabling the ophthalmological company to deliver a holistic sense of well-being around eye health.

article thumbnail

Advancing real-world evidence for pharmaceutical companies in Japan

McKinsey

Pharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.

article thumbnail

Treating rare diseases: How digital technologies can drive innovation

McKinsey

Pharmaceutical companies are using recent advances in digital technologies to improve care strategies and provide hope for rare disease patients across thousands of different rare diseases.